How much is the Breast Cancer Monoclonal Antibodies Market market?

The breast cancer monoclonal antibodies market market size is estimated to grow at $$ 19.2 bn in 2023. Read More

What is the growth rate of the Breast Cancer Monoclonal Antibodies Market market?

The growth rate of the breast cancer monoclonal antibodies market year-over-year is 13.97%. Read More

Which region held the largest market share in the Breast Cancer Monoclonal Antibodies Market market?

North America is the region to held the largest market share with 41% growth. Read More

Who are the key players in the Breast Cancer Monoclonal Antibodies Market market?

Amgen Inc., AstraZeneca Plc, Boehringer Ingelheim International GmbH, Bristol Myers Squibb Co., Celldex Therapeutics Inc, Celltrion Co. Ltd., Daiichi Sankyo Co. Ltd., Eisai Co. Ltd., .... Read More

Which Segment has the largest market share in the Breast Cancer Monoclonal Antibodies Market market?

End-user is the segment that has the largest market share in the market. Read More

Breast Cancer Monoclonal Antibodies Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, France, China, The Netherlands, Canada - Size and Forecast 2024-2028

Published: Jul 2024
Pages: 182
SKU: IRTNTR75974

Enjoy complimentary customisation on priority with our Enterprise License!

1 Executive Summary

1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by End-user
- Executive Summary - Chart on Market Segmentation by Type
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning

2 Market Landscape

2.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market

2.2 Market characteristics
- Market characteristics analysis

2.3 Value chain analysis
- Value Chain Analysis

3 Market Sizing

3.1 Market definition
- Offerings of companies included in the market definition

3.2 Market segment analysis
- Market segments

3.3 Market size 2023

3.4 Market outlook: Forecast for 2023-2028
- Chart on Global - Market size and forecast 2023-2028 ($ billion)
- Data Table on Global - Market size and forecast 2023-2028 ($ billion)
- Chart on Global Market: Year-over-year growth 2023-2028 (%)
- Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

4.1 Global Breast Cancer Monoclonal Antibodies Market 2018 - 2022
- Historic Market Size - Data Table on Global Breast Cancer Monoclonal Antibodies Market 2018 - 2022 ($ billion)

4.2 End-user segment analysis 2018 - 2022
- Historic Market Size - End-user Segment 2018 - 2022 ($ billion)

4.3 Type segment analysis 2018 - 2022
- Historic Market Size - Type Segment 2018 - 2022 ($ billion)

4.4 Geography segment analysis 2018 - 2022
- Historic Market Size - Geography Segment 2018 - 2022 ($ billion)

4.5 Country segment analysis 2018 - 2022
- Historic Market Size - Country Segment 2018 - 2022 ($ billion)

5 Five Forces Analysis

5.1 Five forces summary
- Five forces analysis - Comparison between 2023 and 2028

5.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2023 and 2028

5.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2023 and 2028

5.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2023 and 2028

5.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2023 and 2028

5.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2023 and 2028

5.7 Market condition
- Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by End-user

6.1 Market segments
- Chart on End-user - Market share 2023-2028 (%)
- Data Table on End-user - Market share 2023-2028 (%)

6.2 Comparison by End-user
- Chart on Comparison by End-user
- Data Table on Comparison by End-user

6.3 Hospitals - Market size and forecast 2023-2028
- Chart on Hospitals - Market size and forecast 2023-2028 ($ billion)
- Data Table on Hospitals - Market size and forecast 2023-2028 ($ billion)
- Chart on Hospitals - Year-over-year growth 2023-2028 (%)
- Data Table on Hospitals - Year-over-year growth 2023-2028 (%)

6.4 Research institutes - Market size and forecast 2023-2028
- Chart on Research institutes - Market size and forecast 2023-2028 ($ billion)
- Data Table on Research institutes - Market size and forecast 2023-2028 ($ billion)
- Chart on Research institutes - Year-over-year growth 2023-2028 (%)
- Data Table on Research institutes - Year-over-year growth 2023-2028 (%)

6.5 Others - Market size and forecast 2023-2028
- Chart on Others - Market size and forecast 2023-2028 ($ billion)
- Data Table on Others - Market size and forecast 2023-2028 ($ billion)
- Chart on Others - Year-over-year growth 2023-2028 (%)
- Data Table on Others - Year-over-year growth 2023-2028 (%)

6.6 Market opportunity by End-user
- Market opportunity by End-user ($ billion)
- Data Table on Market opportunity by End-user ($ billion)

7 Market Segmentation by Type

7.1 Market segments
- Chart on Type - Market share 2023-2028 (%)
- Data Table on Type - Market share 2023-2028 (%)

7.2 Comparison by Type
- Chart on Comparison by Type
- Data Table on Comparison by Type

7.3 Humanized - Market size and forecast 2023-2028
- Chart on Humanized - Market size and forecast 2023-2028 ($ billion)
- Data Table on Humanized - Market size and forecast 2023-2028 ($ billion)
- Chart on Humanized - Year-over-year growth 2023-2028 (%)
- Data Table on Humanized - Year-over-year growth 2023-2028 (%)

7.4 Human - Market size and forecast 2023-2028
- Chart on Human - Market size and forecast 2023-2028 ($ billion)
- Data Table on Human - Market size and forecast 2023-2028 ($ billion)
- Chart on Human - Year-over-year growth 2023-2028 (%)
- Data Table on Human - Year-over-year growth 2023-2028 (%)

7.5 Chimeric - Market size and forecast 2023-2028
- Chart on Chimeric - Market size and forecast 2023-2028 ($ billion)
- Data Table on Chimeric - Market size and forecast 2023-2028 ($ billion)
- Chart on Chimeric - Year-over-year growth 2023-2028 (%)
- Data Table on Chimeric - Year-over-year growth 2023-2028 (%)

7.6 Murine - Market size and forecast 2023-2028
- Chart on Murine - Market size and forecast 2023-2028 ($ billion)
- Data Table on Murine - Market size and forecast 2023-2028 ($ billion)
- Chart on Murine - Year-over-year growth 2023-2028 (%)
- Data Table on Murine - Year-over-year growth 2023-2028 (%)

7.7 Market opportunity by Type
- Market opportunity by Type ($ billion)
- Data Table on Market opportunity by Type ($ billion)

8 Customer Landscape

8.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
- Chart on Market share by geography 2023-2028 (%)
- Data Table on Market share by geography 2023-2028 (%)

9.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison

9.3 North America - Market size and forecast 2023-2028
- Chart on North America - Market size and forecast 2023-2028 ($ billion)
- Data Table on North America - Market size and forecast 2023-2028 ($ billion)
- Chart on North America - Year-over-year growth 2023-2028 (%)
- Data Table on North America - Year-over-year growth 2023-2028 (%)

9.4 Europe - Market size and forecast 2023-2028
- Chart on Europe - Market size and forecast 2023-2028 ($ billion)
- Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
- Chart on Europe - Year-over-year growth 2023-2028 (%)
- Data Table on Europe - Year-over-year growth 2023-2028 (%)

9.5 Asia - Market size and forecast 2023-2028
- Chart on Asia - Market size and forecast 2023-2028 ($ billion)
- Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
- Chart on Asia - Year-over-year growth 2023-2028 (%)
- Data Table on Asia - Year-over-year growth 2023-2028 (%)

9.6 Rest of World (ROW) - Market size and forecast 2023-2028
- Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
- Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
- Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)

9.7 US - Market size and forecast 2023-2028
- Chart on US - Market size and forecast 2023-2028 ($ billion)
- Data Table on US - Market size and forecast 2023-2028 ($ billion)
- Chart on US - Year-over-year growth 2023-2028 (%)
- Data Table on US - Year-over-year growth 2023-2028 (%)

9.8 France - Market size and forecast 2023-2028
- Chart on France - Market size and forecast 2023-2028 ($ billion)
- Data Table on France - Market size and forecast 2023-2028 ($ billion)
- Chart on France - Year-over-year growth 2023-2028 (%)
- Data Table on France - Year-over-year growth 2023-2028 (%)

9.9 China - Market size and forecast 2023-2028
- Chart on China - Market size and forecast 2023-2028 ($ billion)
- Data Table on China - Market size and forecast 2023-2028 ($ billion)
- Chart on China - Year-over-year growth 2023-2028 (%)
- Data Table on China - Year-over-year growth 2023-2028 (%)

9.10 The Netherlands - Market size and forecast 2023-2028
- Chart on The Netherlands - Market size and forecast 2023-2028 ($ billion)
- Data Table on The Netherlands - Market size and forecast 2023-2028 ($ billion)
- Chart on The Netherlands - Year-over-year growth 2023-2028 (%)
- Data Table on The Netherlands - Year-over-year growth 2023-2028 (%)

9.11 Canada - Market size and forecast 2023-2028
- Chart on Canada - Market size and forecast 2023-2028 ($ billion)
- Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
- Chart on Canada - Year-over-year growth 2023-2028 (%)
- Data Table on Canada - Year-over-year growth 2023-2028 (%)

9.12 Market opportunity by geography
- Market opportunity by geography ($ billion)
- Data Tables on Market opportunity by geography ($ billion)

10 Drivers, Challenges, and Opportunity/Restraints

10.1 Market drivers

10.2 Market challenges

10.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2023 and 2028

10.4 Market opportunities/restraints

11 Competitive Landscape

11.1 Overview

11.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation

11.3 Landscape disruption
- Overview on factors of disruption

11.4 Industry risks
- Impact of key risks on business

12 Competitive Analysis

12.1 Companies profiled
- Companies covered

12.2 Market positioning of companies
- Matrix on companies position and classification

12.3 Amgen Inc.
- Amgen Inc. - Overview
- Amgen Inc. - Product / Service
- Amgen Inc. - Key news
- Amgen Inc. - Key offerings

12.4 AstraZeneca Plc
- AstraZeneca Plc - Overview
- AstraZeneca Plc - Product / Service
- AstraZeneca Plc - Key news
- AstraZeneca Plc - Key offerings

12.5 Boehringer Ingelheim International GmbH
- Boehringer Ingelheim International GmbH - Overview
- Boehringer Ingelheim International GmbH - Product / Service
- Boehringer Ingelheim International GmbH - Key news
- Boehringer Ingelheim International GmbH - Key offerings

12.6 Bristol Myers Squibb Co.
- Bristol Myers Squibb Co. - Overview
- Bristol Myers Squibb Co. - Product / Service
- Bristol Myers Squibb Co. - Key news
- Bristol Myers Squibb Co. - Key offerings

12.7 Celldex Therapeutics Inc
- Celldex Therapeutics Inc - Overview
- Celldex Therapeutics Inc - Product / Service
- Celldex Therapeutics Inc - Key offerings

12.8 Daiichi Sankyo Co. Ltd.
- Daiichi Sankyo Co. Ltd. - Overview
- Daiichi Sankyo Co. Ltd. - Product / Service
- Daiichi Sankyo Co. Ltd. - Key news
- Daiichi Sankyo Co. Ltd. - Key offerings

12.9 F. Hoffmann La Roche Ltd.
- F. Hoffmann La Roche Ltd. - Overview
- F. Hoffmann La Roche Ltd. - Business segments
- F. Hoffmann La Roche Ltd. - Key news
- F. Hoffmann La Roche Ltd. - Key offerings
- F. Hoffmann La Roche Ltd. - Segment focus

12.10 Gilead Sciences Inc.
- Gilead Sciences Inc. - Overview
- Gilead Sciences Inc. - Product / Service
- Gilead Sciences Inc. - Key news
- Gilead Sciences Inc. - Key offerings

12.11 Johnson and Johnson Services Inc.
- Johnson and Johnson Services Inc. - Overview
- Johnson and Johnson Services Inc. - Business segments
- Johnson and Johnson Services Inc. - Key news
- Johnson and Johnson Services Inc. - Key offerings
- Johnson and Johnson Services Inc. - Segment focus

12.12 MacroGenics Inc.
- MacroGenics Inc. - Overview
- MacroGenics Inc. - Product / Service
- MacroGenics Inc. - Key offerings

12.13 Merck KGaA
- Merck KGaA - Overview
- Merck KGaA - Business segments
- Merck KGaA - Key news
- Merck KGaA - Key offerings
- Merck KGaA - Segment focus

12.14 Novartis AG
- Novartis AG - Overview
- Novartis AG - Business segments
- Novartis AG - Key news
- Novartis AG - Key offerings
- Novartis AG - Segment focus

12.15 Pfizer Inc.
- Pfizer Inc. - Overview
- Pfizer Inc. - Product / Service
- Pfizer Inc. - Key news
- Pfizer Inc. - Key offerings

12.16 Sanofi SA
- Sanofi SA - Overview
- Sanofi SA - Business segments
- Sanofi SA - Key news
- Sanofi SA - Key offerings
- Sanofi SA - Segment focus

12.17 Viatris Inc.
- Viatris Inc. - Overview
- Viatris Inc. - Business segments
- Viatris Inc. - Key news
- Viatris Inc. - Key offerings
- Viatris Inc. - Segment focus

13 Appendix